⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVCT News
Nuvectis Pharma, Inc. Common Stock
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
globenewswire.com
NVCT
Form 8-K
sec.gov
NVCT
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
globenewswire.com
NVCT
Form 8-K
sec.gov
NVCT
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds
globenewswire.com
NVCT
Form 8-K
sec.gov
NVCT
Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
globenewswire.com
NVCT
Form 8-K
sec.gov
NVCT
Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights
globenewswire.com
NVCT
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting
globenewswire.com
NVCT